Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.77 | N/A |
| PEG Ratio (TTM) | 0.44 | N/A |
| P/S Ratio (TTM) | 1.22 | N/A |
| P/B Ratio (TTM) | 1.76 | N/A |
| P/FCF Ratio (TTM) | 8.75 | N/A |
| Price to 5YR AVG Earnings Ratio | 46.21 | N/A |
| Price to 5YR AVG FCF Ratio | 36.45 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.50% | N/A |
| ROE (TTM) | 11.02% | N/A |
| Net Profit Margin (TTM) | 7.29% | N/A |
| ROIC 5YR AVG | -1.05% | N/A |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 67.39% | 442.35% | 249.22% |
| Revenue | 4.55% | -2.87% | -0.04% |
| Net Income | 65.72% | 444.36% | 249.07% |
| Cash Flow | 2.91% | 3.00% | 4.01% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.86 | N/A |
| Quick Ratio (TTM) | 0.76 | N/A |
| D/E Ratio (TTM) | 1.17 | N/A |
| Interest Coverage (TTM) | 3.21 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.69 | N/A |
| LTL to 5YR AVG FCF | 23.47 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.14% | N/A |